Biotech Analytics & Advisory
Modulus
Biotech
Data · Insight · Impact

Modulus Biotech specializes in biopharmaceutical business development. We link drug discovery scientists with pharmaceutical companies. Our expertise is in identifying, structuring, negotiating, and managing co-development partnerships, license agreements, and other commercial transactions in the pharmaceutical and biotechnology sectors. We provide exclusive scientific representation to distinguished scientists whose patented and near-patented molecules sit at the cutting edge of bioscience, structuring the pharma co-development deals that advance those discoveries from the laboratory into clinical development. Our practice focuses on rare diseases and oncology — the therapeutic areas where breakthrough science means the most.

For Scientist → Contact us
About Modulus Biotech

Between 2025 and 2030, a wave of major patent expirations is pulling billions in annual revenue out of large pharma's established portfolios — a financial cliff driving urgent demand for new pipeline assets. Modulus represents the scientists whose molecules can fill that gap.

Our incentives align with the discovery, the inventor, and the advancement of meaningful therapeutic outcomes — particularly in rare diseases and oncology, where the successful translation of these molecules into approved therapies depends on disciplined representation.

What we do

Exclusive scientific representation

We work directly and exclusively with scientists whose molecules sit at the cutting edge of bioscience — protecting their interests, managing the business side, and freeing them to stay focused on the research.

Pharma co-development deals

We identify, negotiate, and manage co-development partnerships, license agreements, and commercial transactions on your behalf.

Rare diseases & oncology focus

Special emphasis on the therapeutic areas where breakthrough science means the most: rare and orphan diseases, and oncology — the indications where conventional development pipelines have historically fallen short.

Targeted pharma outreach

We identify and approach the specific pharmaceutical companies whose pipelines, therapeutic focus, and development stage make them real candidates — not blast lists.

Deal structuring & negotiation

Term sheets, milestone payments, royalty structures, co-development economics — we negotiate the agreement the science deserves, not the first one offered.

Confidentiality & advocacy

Every conversation, every disclosure, every term sheet — held in strictest confidence. We are the scientist's voice in every room they're not in, and the firewall protecting their work in every room they are.

Founder & CEO
Anthony Modafferi
Founder & Chief Executive Officer

As Chief Executive Officer at Modulus Biotech, I lead our mission to bring transformative antiviral and cancer drugs to market.

If you are a distinguished scientist and have a proven record of successfully participating in bringing new drugs to market, we would like to hear from you to discuss how you can bypass traditional mechanisms for drug development. If you are interested in hearing how we can assist you, please provide your information in the inquiry section. All communications are held in strictest confidence.

Over 10 years experience in infectious disease and general acute care hospitals at C-suite level.

Education
J.D., Seton Hall
Education
B.S. in Finance, Seton Hall
Experience
10+ years C-suite, healthcare
Reach Anthony directly → LinkedIn
Get in touch

Got a question, an idea, or just want to say hi? Drop Anthony a line. He reads everything, and replies personally.

AM
Anthony Modafferi
Founder & CEO · Replies personally, usually within 24 hours
Enter to send · opens your email client to send to anthony@modulusbiotech.ai
Or email directly: anthony@modulusbiotech.ai
Pharmaceutical Companies

For pharma and biotech business development teams searching for the next pipeline asset: Modulus provides direct, vetted access to distinguished scientists whose patented and near-patented molecules sit at the frontline of drug discovery. We identify, screen, and represent inventors whose work meets the strategic and therapeutic profile your organization is targeting — with particular depth in rare diseases and oncology.

Whether you are sourcing a Phase 1-ready asset to fill a pipeline gap, evaluating a license opportunity, or structuring a multi-stage co-development partnership, our role is to put the right inventor in front of the right team, under the right diligence framework, with confidentiality protected at every step.

Pharma BD Intake

Tell us what you're looking for.

All inquiries are reviewed personally and held in strict confidence. Share what you're comfortable sharing here — anything sensitive can be expanded under an NDA before further discussion.

Drug Discovery Scientist

We represent distinguished drug discovery scientists with proven records of discovering patented or near-patented molecules at the cutting edge of bioscience — with special emphasis on rare diseases and oncology. Submit the form below to begin a conversation about exclusive representation.

Scientist Intake

Tell us about your work.

All submissions are reviewed personally and held in strict confidence. Please share what you're comfortable sharing publicly — anything sensitive can be expanded under an NDA before further discussion.

Submitting opens your email client with this intake addressed to Anthony Modafferi.